Question: Lymecycline is marketed by the company that became a subsidiary of what multinational in 2014?

full_context: Document 1: Nestlé Purina PetCare: Nestlé Purina Petcare is a St. Louis, Missouri-based subsidiary of Nestlé. It produces and markets pet food, treats and litter. Some of its pet food brands include Purina Pro Plan, Purina Dog Chow, Friskies, Beneful and Purina ONE. The company was formed in 2001 by combining Ralston Purina, which was acquired by Nestlé for $10.3 billion, with Nestlé's Friskies Petcare Company. As consumers became willing to spend more money on their pets, the company grew. As of 2012, it is the second-largest pet food company globally and the largest in the United States.
Document 2: Nonactin: Nonactin is a member of a family of naturally occurring cyclic ionophores known as the macrotetrolide antibiotics. The other members of this homologous family are monactin, dinactin, trinactin and tetranactin which are all neutral ionophoric substances and higher homologs of nonactin. Collectively, this class is known as the nactins. Nonactin is soluble in methanol, dichloromethane, ethyl acetate and DMSO, but insoluble in water.
Document 3: Galderma: Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014.
Document 4: Walgreens Boots Alliance: Walgreens Boots Alliance, Inc. is an American holding company headquartered in Deerfield, Illinois that owns Walgreens, Boots and a number of pharmaceutical manufacturing, wholesale and distribution companies. The company was formed on December 31, 2014 after Walgreens purchased the 55% stake in Switzerland-based Alliance Boots that it did not already own. Walgreens had previously purchased 45% of the company in 2012 with an option to purchase the remaining shares within three years.
Document 5: Driclor: Driclor is a strong anti-perspirant manufactured by Stiefel Laboratories (UK) and produced in Sligo, Ireland. Driclor is similar to other strong anti-perspirants using 20% aluminium chloride hexahydrate as the active ingredient, however, the water content and roll-on dispenser may cause skin irritancy as water / perspiration can break down the active ingredient to produce hydrochloric acid.
Document 6: Braun (company): Braun GmbH ( ; ] ), formerly Braun AG, is a German consumer products company based in Kronberg. From 1984 until 2007, Braun was a wholly owned subsidiary of The Gillette Company, which had purchased a controlling interest in the company in 1967. Braun is now a wholly owned subsidiary of Procter & Gamble, which acquired Gillette in 2005. On 16 April 2012, De'Longhi bought perpetual rights to manufacture Braun branded products from Procter & Gamble in the small appliance segment. Procter & Gamble will continue to own the Braun brand.
Document 7: Palmitoyl pentapeptide-4: Palmitoyl pentapeptide-4 (palmitoyl pentapeptide-3 before 2006) is a matrikine used in anti-wrinkle cosmetics. It was launched in 2000 as an active ingredient for the personal care industry under the trade name Matrixyl by the French cosmetic active ingredient manufacturer Sederma SAS.
Document 8: Chattem: Chattem is an American, Chattanooga, Tennessee-based, producer and marketer of over-the-counter healthcare products, toiletries, dietary supplements, topical analgesics, and medicated skin care products. Originally named the Chattanooga Medicine Company, the company’s brand portfolio holds twenty-two brands including Allegra, Gold Bond, Flexall, IcyHot, Rolaids, Sun-In, Pamprin, Dexatrim, Aspercreme, and Selsun Blue. Two-thirds of Chattem’s products are produced by the company at its Chattanooga production facilities with the remaining produced by third-party producers. The company is a subsidiary of the French multinational pharmaceutical company Sanofi.
Document 9: Freederm: Freederm is a UK brand of acne and skin care medication manufactured by Diomed Developments Limited. The products include Nicotinamide as an active ingredient, which is claimed by the company to be "clinically proven to help get rid of inflamed red spots".
Document 10: Nivea: Nivea (] ) is a German personal care brand that specializes in skin- and body-care. It is owned by the Hamburg-based company Beiersdorf Global AG. The company was founded on March 28, 1882, by pharmacist Paul Carl Beiersdorf. In 1890, it was sold to Oscar Troplowitz. Troplowitz kept working with his scientific consultant Paul Gerson Unna and the German chemist Isaac Lifschütz on a new skin care cream. In 1900, Lifschütz developed a water-in-oil emulsion as a skin cream with Eucerit, the first stable emulsion of its kind. This was the basis for Eucerin and, later, Nivea. "Nivea" comes from the Latin word "niveus/nivea/niveum", meaning "snow-white".
Document 11: Cyclophosphamide: Cyclophosphamide (CP), also known as cytophosphane among other, is a medication used as chemotherapy and to suppress the immune system. As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. As an immune suppressor it is used in nephrotic syndrome and following organ transplant. It is taken by mouth or injection into a vein.
Document 12: Lymecycline: Lymecycline is a tetracycline broad-spectrum antibiotic marketed by the pharmaceutical company Galderma. It is approximately 5,000 times more soluble than tetracycline base and is unique amongst tetracyclines in that it is absorbed by an active transport process across the intestinal wall, making use of the same fast and efficient mechanism by which carbohydrates are absorbed.
Document 13: GlaxoSmithKline Pharmaceuticals Ltd: GlaxoSmithKline Pharmaceuticals Ltd ( ) is an Indian subsidiary of GlaxoSmithKline plc, one of the world's leading research based pharmaceutical and healthcare companies. It is one of the oldest pharmaceuticals companies in India. It product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer and others.
Document 14: Selsun Blue: Selsun Blue is an over-the-counter brand of dandruff shampoo now owned by Sanofi. First made by Abbott Laboratories, the brand was bought by Chattem in 2002. Chattem was acquired by Sanofi in 2010. Selsun Blue has been marketed as a more effective alternative to brand leader Head & Shoulders due to its superior performance in randomized trials.
Document 15: Boots UK: Boots UK (formerly Boots the Chemists Ltd.), trading as Boots, is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. The company's former parent, The Boots Company Plc, merged with Alliance UniChem in 2006 to form Alliance Boots. In 2007, Alliance Boots was bought by Kohlberg Kravis Roberts and Stefano Pessina, taking the company private, and moving its headquarters to Switzerland, the first ever FTSE 100 company bought by a private equity firm. In 2012, Walgreens bought a 45% stake in Alliance Boots, with the option to buy the rest within three years. It exercised this option in 2014, and as a result Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.
ground_truth: Nestlé